CVS Health (CVS): One of the Best Blue Chip Stocks Under $100 to Buy Now
Key takeaways
- On June 1, Truist lifted its price objective on the company’s stock to $108 from $102 and maintained a “Buy” rating on the shares.
- Furthermore, there are expectations of continued robust trends in the commercial business.
- Notably, in Q1 2026, CVS Health Corporation (NYSE:CVS)’s total revenues came in at $100.4 billion, reflecting a rise of 6.2% YoY, with GAAP diluted EPS coming at $2.30 and adjusted EPS at $2.57.
CVS Health (CVS): One of the Best Blue Chip Stocks Under $100 to Buy Now Bob Karr Mon, June 8, 2026 at 11:15 PM GMT+7 1 min read CVS TFC CVS Health Corporation (NYSE:CVS) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On June 1, Truist lifted its price objective on the company’s stock to $108 from $102 and maintained a “Buy” rating on the shares. This forms part of the research note on the broader managed healthcare companies. The analyst highlighted that the firm expects significant embedded earnings potential that is associated with the ongoing margin recovery throughout the government businesses.
Furthermore, there are expectations of continued robust trends in the commercial business. The firm added that the Q1 medical cost trends were favourable to the consensus expectations of the analysts.
Notably, in Q1 2026, CVS Health Corporation (NYSE:CVS)’s total revenues came in at $100.4 billion, reflecting a rise of 6.2% YoY, with GAAP diluted EPS coming at $2.30 and adjusted EPS at $2.57. The company raised its FY 2026 guidance, with GAAP diluted EPS now expected to be between $6.24 – $6.44 compared to the previous range of $5.94 – $6.14.